TrialJournal of substance abuse treatment2021

Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials Network.

LaTrice Montgomery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.